Best Peptides for Hair Growth

Hair loss affects roughly 50 million men and 30 million women in the United States alone, driven by androgenetic alopecia, hormonal changes, nutritional deficiencies, and age-related follicle miniaturization. Current FDA-approved treatments — minoxidil and finasteride — work for many people but have limitations in efficacy and side effect profiles. Peptides represent an emerging area of hair loss research, targeting hair follicle biology through growth factor signaling, stem cell activation, improved scalp circulation, and cellular anti-aging mechanisms.

The peptides below are ranked by the directness and quality of available evidence for hair-related benefits. It is important to note that most peptide hair research remains preclinical — conducted in cell cultures and animal models rather than large-scale human clinical trials. GHK-Cu stands apart with the most direct follicle-level evidence, while the remaining compounds offer indirect or early-stage mechanisms that may support hair health.

1. GHK-Cu — Best Overall for Hair Follicle Stimulation

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide-copper complex and the most directly studied peptide for hair growth applications. It was first identified in human plasma and declines significantly with age. Research has demonstrated that GHK-Cu stimulates hair follicle growth, increases follicle size, and extends the anagen (active growth) phase of the hair cycle. In vitro studies show that GHK-Cu upregulates genes involved in hair follicle development and promotes proliferation of dermal papilla cells — the signaling hub that controls hair growth and cycling.

The copper component of GHK-Cu plays a critical role in its hair benefits. Copper is a cofactor for lysyl oxidase, an enzyme essential for collagen and elastin cross-linking in the scalp extracellular matrix. GHK-Cu also stimulates the production of vascular endothelial growth factor (VEGF), improving blood supply to hair follicles. Studies comparing GHK-Cu to minoxidil have found that copper peptides can stimulate hair growth through complementary mechanisms — promoting follicle enlargement rather than primarily acting as a vasodilator.

GHK-Cu is available in topical formulations including serums and scalp treatments, making it one of the most accessible peptides for hair applications. Its small molecular weight allows effective scalp penetration. Research protocols typically use topical concentrations of 1 to 3 percent applied daily to the scalp. Some practitioners also use subcutaneous injection at 1 to 2mg daily for systemic benefits. GHK-Cu has a well-established safety profile with decades of dermatological research, though dedicated large-scale hair loss clinical trials are still needed.

2. BPC-157 — Scalp Circulation and VEGF Upregulation

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protective protein found in human gastric juice. While primarily studied for musculoskeletal and gut healing, BPC-157's mechanism of action has significant implications for hair growth. Its primary relevance to hair follicle health is through angiogenesis — the formation of new blood vessels. BPC-157 potently upregulates vascular endothelial growth factor (VEGF) and stimulates the formation of new capillary networks. Since hair follicles are among the most metabolically active structures in the body, their health depends heavily on adequate blood supply.

Follicle miniaturization in androgenetic alopecia is associated with reduced perifollicular vasculature — the network of tiny blood vessels surrounding each follicle. By promoting angiogenesis, BPC-157 may help restore nutrient delivery and oxygen supply to shrinking follicles, supporting their return to a healthier growth state. BPC-157 also modulates the nitric oxide system and reduces pro-inflammatory cytokines, potentially addressing scalp inflammation (a contributing factor in several types of hair loss including alopecia areata and scarring alopecias).

It is important to note that BPC-157 has not been directly studied in hair loss models. Its potential for hair growth is extrapolated from its well-documented vascular and tissue-healing mechanisms. Research protocols typically use 250 to 500mcg administered subcutaneously once or twice daily. Whether localized scalp injection would provide additional benefit over systemic administration is not established. BPC-157 is investigational and not FDA-approved for any indication.

3. Thymosin Beta-4 (TB-500) — Hair Follicle Stem Cell Activation

TB-500 is a synthetic version of Thymosin Beta-4, a naturally occurring 43-amino-acid peptide found in nearly all human and animal cells. Unlike the other peptides on this list, Thymosin Beta-4 has been directly studied for its effects on hair follicle biology in published research. A landmark study published in the Proceedings of the National Academy of Sciences demonstrated that Thymosin Beta-4 promotes hair growth in mice by activating hair follicle stem cells in the bulge region of the follicle. These stem cells are critical for initiating new hair growth cycles and regenerating the follicle structure during anagen.

The research showed that Thymosin Beta-4 accelerated hair shaft elongation and promoted the transition of follicles from the telogen (resting) phase into the anagen (growth) phase. Its mechanism involves upregulating actin — a structural protein essential for cell migration and tissue repair — which helps stem cells mobilize from the bulge niche to the base of the follicle where new hair growth is initiated. Thymosin Beta-4 also promotes angiogenesis and extracellular matrix remodeling, both of which support the perifollicular environment needed for healthy hair production.

While these animal model results are promising, translation to human hair loss treatment remains unproven. Research protocols for TB-500 typically use 2 to 2.5mg administered subcutaneously twice per week. Whether systemic administration provides sufficient concentration at the scalp level to replicate the animal study results is not established. TB-500 is investigational, not FDA-approved, and its specific application to human hair loss requires further clinical research.

4. Epitalon — Telomerase Activation and Follicle Stem Cell Longevity

Epitalon (also known as Epithalon) is a synthetic tetrapeptide based on the natural peptide epithalamin, which is produced by the pineal gland. Its primary mechanism of action is the activation of telomerase, the enzyme responsible for maintaining telomere length at the ends of chromosomes. Telomere shortening is a fundamental driver of cellular aging, and hair follicle stem cells are not exempt from this process. As follicle stem cells accumulate divisions over decades, their telomeres shorten, reducing their proliferative capacity and contributing to the progressive follicle miniaturization seen in age-related hair thinning.

By activating telomerase, Epitalon may help preserve the replicative potential of hair follicle stem cells, slowing the cellular aging process that contributes to reduced hair density over time. Research by Khavinson and colleagues has demonstrated that Epitalon increases telomerase activity in human somatic cells and extends the lifespan of cell cultures. The connection to hair growth is indirect but mechanistically sound — healthier, longer-lived stem cells in the follicle bulge should maintain their ability to regenerate follicles through more hair cycles.

Epitalon has not been directly studied in hair loss models, and its potential hair benefits are extrapolated from its anti-aging cellular mechanisms. Research protocols typically use 5 to 10mg administered subcutaneously daily for 10 to 20 day cycles, repeated every 4 to 6 months. Its effects on hair would be expected to develop very gradually over months to years as cellular aging processes are modulated. Epitalon is investigational and not FDA-approved. It is best understood as a long-term anti-aging strategy that may indirectly benefit hair follicle longevity rather than a direct hair growth treatment.

5. Ipamorelin — GH-Mediated Hair Cycle Support via IGF-1

Ipamorelin is a selective growth hormone secretagogue that stimulates the pituitary gland to release natural growth hormone without significantly affecting cortisol or prolactin levels. Its relevance to hair growth is mediated through the GH/IGF-1 axis — a hormonal pathway with well-documented effects on hair follicle biology. IGF-1 (insulin-like growth factor 1), produced primarily in the liver in response to growth hormone, is a key regulator of the hair growth cycle. It promotes keratinocyte proliferation in the hair matrix, supports the anagen phase, and has been shown to protect follicles from premature entry into the catagen (regression) phase.

Clinical observations support the GH-hair connection: growth hormone deficiency in adults is associated with thinner, finer hair and reduced hair density. GH replacement therapy has been shown to improve hair quality in GH-deficient patients. As natural GH production declines with age (approximately 14 percent per decade after age 30), the corresponding drop in IGF-1 may contribute to the progressive hair thinning experienced by many adults. Ipamorelin aims to restore more youthful GH pulsatility, which may in turn support healthier IGF-1 levels and improved hair cycle dynamics.

Standard research protocols use 200 to 300mcg administered subcutaneously before bed to align with natural GH pulse patterns. Hair-related benefits from ipamorelin would be expected to develop gradually over 4 to 6 months as sustained GH and IGF-1 elevation influences the hair growth cycle. Ipamorelin is not a targeted hair loss treatment — its hair benefits are secondary to its broader hormonal effects. It is not FDA-approved and should be used under medical supervision with monitoring of IGF-1 levels.

Hair Growth Peptides Comparison Table

How to Choose the Right Peptide for Hair Growth

Start by understanding what type of hair loss you are experiencing. For general hair thinning and miniaturization, GHK-Cu is the strongest first choice because it has the most direct evidence for follicle stimulation and is available in topical formulations that can be applied directly to the scalp without injections. Its accessibility and established safety profile make it the most practical entry point for peptide-based hair support. If you are already using minoxidil or finasteride, GHK-Cu may work through complementary mechanisms and some practitioners layer copper peptide serums into existing regimens.

For those open to injectable peptides, BPC-157 and TB-500 offer different mechanistic angles — improved scalp vasculature and follicle stem cell activation respectively. If age-related hair thinning is your primary concern and you are over 40, ipamorelin addresses the declining GH/IGF-1 axis that contributes to reduced hair quality with aging. Epitalon is the most speculative option, best suited for those pursuing a broad anti-aging strategy rather than targeted hair regrowth. Regardless of which peptide you consider, hair growth is a slow process requiring 3 to 6 months minimum before visible changes. Set realistic expectations, document your baseline with photographs, and work with a dermatologist or healthcare provider who can monitor your progress and adjust protocols appropriately.

Frequently Asked Questions